Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity
Authors:
- Ilia A. BolosovIBIlia A. Bolosov
- Pavel V. PanteleevPPPavel V. Panteleev
- Sergei V. SychevSSSergei V. Sychev
- Veronika A. KhokhlovaVKVeronika A. Khokhlova
- Victoria N. SafronovaVSVictoria N. Safronova
- Ilia Yu. ToropyginITIlia Yu. Toropygin
- Tatiana I. KombarovaTKTatiana I. Kombarova
- Olga V. KorobovaOKOlga V. Korobova
- Eugenia S. PereskokovaEPEugenia S. Pereskokova
- Alexander I. BorzilovABAlexander I. Borzilov
- Tatiana V. OvchinnikovaTOTatiana V. Ovchinnikova
- Sergey V. BalandinSergey V. Balandin
Open Access
- 30 July 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (8) , 2047
Abstract
Protegrin-1 (PG-1) is a cationic β-hairpin pore-forming antimicrobial peptide having a membranolytic mechanism of action. It possesses in vitro a potent antimicrobial activity against a panel of clinically relevant MDR ESKAPE pathogens. However, its extremely high hemolytic activity and cytotoxicity toward mammalian cells prevent the further development of the protegrin-based antibiotic for systemic administration. In this study, we rationally modulated the PG-1 charge and hydrophobicity by substituting selected residues in the central β-sheet region of PG-1 to design its analogs, which retain a high antimicrobial activity but have a reduced toxicity toward mammalian cells. In this work, eight PG-1 analogs with single amino acid substitutions and five analogs with double substitutions were obtained. These analogs were produced as thioredoxin fusions in Escherichia coli. It was shown that a significant reduction in hemolytic activity without any loss of antimicrobial activity could be achieved by a single amino acid substitution, V16R in the C-terminal β-strand, which is responsible for the PG-1 oligomerization. As the result, a selective analog with a ≥30-fold improved therapeutic index was obtained. FTIR spectroscopy analysis of analog, [V16R], revealed that the peptide is unable to form oligomeric structures in a membrane-mimicking environment, in contrast to wild-type PG-1. Analog [V16R] showed a reasonable efficacy in septicemia infection mice model as a systemic antibiotic and could be considered as a promising lead for further drug design.Keywords
Funding Information
- Russian Science Foundation (22-25-00496)
This publication has 46 references indexed in Scilit:
- Cathelicidins: family of antimicrobial peptides. A reviewMolecular Biology Reports, 2012
- Criterion for Amino Acid Composition of Defensins and Antimicrobial Peptides Based on Geometry of Membrane DestabilizationJournal of the American Chemical Society, 2011
- Computational studies of protegrin antimicrobial peptides: A reviewPeptides, 2011
- Antimicrobial Protegrin-1 Forms Ion Channels: Molecular Dynamic Simulation, Atomic Force Microscopy, and Electrical Conductance StudiesBiophysical Journal, 2010
- Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: Predicting experimental toxicityPeptides, 2008
- Comparison of interactions between beta-hairpin decapeptides and SDS/DPC micelles from experimental and simulation dataBMC Biochemistry, 2007
- Membrane-dependent oligomeric structure and pore formation of a β-hairpin antimicrobial peptide in lipid bilayers from solid-state NMRProceedings of the National Academy of Sciences, 2006
- A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)Leukemia & Lymphoma, 2003
- Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesinsFEBS Letters, 1993
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969